Company Filing History:
1 out of 2 
1 out of 1 Years Active: 2007
Title: Liqin Zhao: Innovator in Neurodegenerative Disease Treatment
Introduction
Liqin Zhao is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmacology, particularly in the development of compounds aimed at treating neurodegenerative diseases. His innovative work has garnered attention for its potential impact on medical science.
Latest Patents
Liqin Zhao holds a patent for "Substituted 5-membered n-heterocyclic compounds and their uses for treating or preventing neurodegenerative diseases." This invention relates to substituted 5-membered N-Heterocyclic neurotrophic compounds of formula (I) or pharmaceutically acceptable salts or hydrates thereof. The patent outlines their preparation methods, compositions comprising the same, and their use as inhibitors of FK560 binding proteases (FKBPs) activity for treating and preventing neurodegenerative diseases and other nerve disorders associated with nerve injuries or other related diseases. He has 1 patent to his name.
Career Highlights
Throughout his career, Liqin Zhao has worked at notable institutions such as the Institute of Pharmacology and Toxicology and the Academy of Military Medical Sciences. His work in these organizations has allowed him to focus on research that bridges the gap between pharmacology and neurobiology.
Collaborations
Liqin Zhao has collaborated with esteemed colleagues, including Song Li and Lili Wang. Their combined expertise has contributed to advancements in the understanding and treatment of neurodegenerative conditions.
Conclusion
Liqin Zhao's innovative contributions to the field of neurodegenerative disease treatment highlight his role as a key inventor in pharmacology. His work continues to inspire advancements in medical research and therapeutic development.